Jw Life Science Corp (234080) — Capital Reinvestment Ratio
Latest as of December 2025:
0.84x
Jw Life Science Corp (234080) has a Capital Reinvestment Ratio of 0.84x as of December 2025, meaning it reinvests 1% of its operating cash flow (₩5.08 Billion) in capital expenditures (₩4.27 Billion). See Jw Life Science Corp free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.84x
Capex / Operating Cash Flow
Operating Cash Flow
₩5.08 Billion
KRW
Capital Expenditures
₩4.27 Billion
KRW
Data as of
Dec 2025
Most recent filing
Jw Life Science Corp Capital Reinvestment Ratio (2015–2025)
This chart tracks Jw Life Science Corp's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Jw Life Science Corp (2015–2025)
Year-by-year Capital Reinvestment Ratio for Jw Life Science Corp from 2015 to 2025. For live market cap and broader valuation context, see Jw Life Science Corp market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | ₩40.54 Billion | ₩13.43 Billion | ▲ +63.0% |
| 2024 | 0.20x | ₩50.69 Billion | ₩10.31 Billion | ▼ -7.6% |
| 2023 | 0.22x | ₩37.57 Billion | ₩8.27 Billion | ▼ -62.5% |
| 2022 | 0.59x | ₩14.13 Billion | ₩8.29 Billion | ▼ -6.7% |
| 2021 | 0.63x | ₩30.17 Billion | ₩18.98 Billion | ▲ +84.6% |
| 2020 | 0.34x | ₩46.75 Billion | ₩15.93 Billion | ▲ +2.2% |
| 2019 | 0.33x | ₩24.28 Billion | ₩8.09 Billion | ▲ +19.9% |
| 2018 | 0.28x | ₩36.13 Billion | ₩10.04 Billion | ▼ -30.1% |
| 2017 | 0.40x | ₩22.05 Billion | ₩8.77 Billion | ▼ -52.2% |
| 2016 | 0.83x | ₩16.08 Billion | ₩13.37 Billion | ▼ -7.0% |
| 2015 | 0.89x | ₩25.90 Billion | ₩23.14 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow